ecrin-mdr-crcClinical2015Metastatic Colorectal CancerColorectal cancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2191693United States3Colorectal adenocarcinomaECRIN MDRCompletedfalseRegorafenib in Metastatic Colorectal CancerThe purpose of the study is to measure high grade (3-5) toxicity of regorafenib and to monitor the impact of treatment with regorafenib on the quality of life in older adults with metastatic colorectal cancer.2015-03-152191693NCT02466009